168 related articles for article (PubMed ID: 27003548)
1. Challenges for Managed Care from 340B Contract Pharmacies.
Fein AJ
J Manag Care Spec Pharm; 2016 Mar; 22(3):197-203. PubMed ID: 27003548
[TBL] [Abstract][Full Text] [Related]
2. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
Khandelwal N; Duncan I; Rubinstein E; Ahmed T; Pegus C
J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733
[TBL] [Abstract][Full Text] [Related]
3. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
Carroll NV
J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
[TBL] [Abstract][Full Text] [Related]
4. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
5. The 340b Program, Contract Pharmacies, Hospitals, and Patients: An Evolving Relationship Impacting Health Care Delivery.
Ruley M; Belcher M; Sayre H; Coustasse A
Health Care Manag (Frederick); 2019; 38(4):311-321. PubMed ID: 31663869
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
Johnsrud M; Lawson KA; Shepherd MD
J Manag Care Pharm; 2007 Mar; 13(2):122-34. PubMed ID: 17330973
[TBL] [Abstract][Full Text] [Related]
7. The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012.
Clark BL; Hou J; Chou CH; Huang ES; Conti R
Health Aff (Millwood); 2014 Nov; 33(11):2012-7. PubMed ID: 25367997
[TBL] [Abstract][Full Text] [Related]
8. Formulary management in the Department of Defense.
Trice S; Devine J; Mistry H; Moore E; Linton A
J Manag Care Pharm; 2009 Mar; 15(2):133-46. PubMed ID: 19236127
[TBL] [Abstract][Full Text] [Related]
9. Effective strategies for managing pharmacy benefits.
Jacobson D
Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
[TBL] [Abstract][Full Text] [Related]
10. Comparison of costs of community and mail service pharmacy.
Carroll NV; Brusilovsky I; York B; Oscar R
J Am Pharm Assoc (2003); 2005; 45(3):336-43. PubMed ID: 15991755
[TBL] [Abstract][Full Text] [Related]
11. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
Murry L; Gerleman B; Urick B; Urmie J
J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
[TBL] [Abstract][Full Text] [Related]
12. To Reform Pharmacy Reimbursement Begin with the Basics.
Rupp MT
J Manag Care Spec Pharm; 2020 Jun; 26(6):713-715. PubMed ID: 32463772
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of the 340B Drug Pricing Program: A Scoping Review.
Knox RP; Wang J; Feldman WB; Kesselheim AS; Sarpatwari A
JAMA Health Forum; 2023 Nov; 4(11):e233716. PubMed ID: 37991784
[TBL] [Abstract][Full Text] [Related]
14. Changes in PBM Business Practices in 2019: True Innovation or More of the Same?
Motheral BR; Fairman KA
J Manag Care Spec Pharm; 2020 Oct; 26(10):1325-1333. PubMed ID: 32869706
[TBL] [Abstract][Full Text] [Related]
15. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
Nemlekar P; Shepherd M; Lawson K; Rush S
J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
[TBL] [Abstract][Full Text] [Related]
16. Association of 340B contract pharmacy growth with county-level characteristics.
Nikpay S; Gracia G; Geressu H; Conti R
Am J Manag Care; 2022 Mar; 28(3):133-136. PubMed ID: 35404549
[TBL] [Abstract][Full Text] [Related]
17. Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.
Conti RM; Nikpay SS; Buntin MB
JAMA Netw Open; 2019 Oct; 2(10):e1914141. PubMed ID: 31664442
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a $4 generic drug program in a 340B pharmacy.
Bright DR; Adams AJ; Akala FO; Lengel AJ; Martin SJ; Powers MF
Am J Health Syst Pharm; 2010 Jun; 67(11):929-31. PubMed ID: 20484217
[TBL] [Abstract][Full Text] [Related]
19. Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013.
McPherson T; Fontane P; Iyengar R; Henderson R
J Manag Care Spec Pharm; 2016 Feb; 22(2):172-81. PubMed ID: 27015256
[TBL] [Abstract][Full Text] [Related]
20. Specialty Drug Price Trends in the Federal 340B Drug Discount Program.
Lee CH; Chang J; McCombs J
J Manag Care Spec Pharm; 2019 Feb; 25(2):178-187. PubMed ID: 30698090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
